APELLIS PHARMACEUTICALS INC. - COMMON STOCK
28.06
14-11月-24 15:45:00
15 分の遅延
株式
-0.19
-0.67%
本日の幅
27.81 - 28.87
ISIN
N/A
ソース
NASDAQ
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 12 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Host a Fireside Chat at the 6th Annual Evercore ISI HealthCONx Conference
21 11 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 11 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
04 11 2023 12:37:55 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Third Quarter 2023 Financial Results
01 11 2023 06:05:00 提供 Nasdaq GlobeNewswire
-
25 10 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
20 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
17 10 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 10 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
05 10 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
02 10 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
25 9 2023 06:30:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 9 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
30 8 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
29 8 2023 05:58:00 提供 Nasdaq GlobeNewswire
-
22 8 2023 15:43:29 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 8 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results
31 7 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
30 7 2023 12:00:40 提供 Nasdaq GlobeNewswire
-
29 7 2023 13:52:12 提供 Nasdaq GlobeNewswire